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What’s already known about this topic? 
 A significant rate of sensitisation to oxidised limonene and linalool has been 
demonstrated worldwide  
 Distinguishing true positives from irritant reactions may be difficult 
What does this study add? 
 Higher concentrations of limonene hydroperoxides (0.3%) and linalool 
hydroperoxides (1.0%) detect more sensitised patients 
 Dilutions should be tested in patients with questionable reactions 
What’s new? 
 Limonene hydroperoxides 0.3% and linalool hydroperoxides 1.0% should be added 
to the British baseline patch test series 
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ABSTRACT 
Background: 
There is a significant rate of sensitisation worldwide to the oxidised fragrance terpenes 
limonene and linalool.  Patch testing to oxidised terpenes is not routinely carried out; the 
ideal patch test concentration is unknown.  
Objectives: 
To determine the best test concentrations for limonene and linalool hydroperoxides, added 
to the British baseline patch test series, to optimise detection of true allergy and minimise 
irritant reactions. 
Methods: 
During 2013-2014, 4563 consecutive patients in 12 UK centres were tested to 
hydroperoxides of limonene in petrolatum (pet.) 0.3%, 0.2% and 0.1%, and hydroperoxides 
of linalool 1.0%, 0.5% and 0.25% pet. Irritant (IR) reactions were recorded separately from 
doubtful (?+) reactions. Concomitant reactions to other fragrance markers and clinical 
relevance were documented. 
Results: 
Limonene hydroperoxide 0.3% gave positive reactions in 241 (5.3%) patients, irritant 
reactions in 93 (2.0%) and doubtful reactions in 110 (2.4%). Linalool hydroperoxide 1.0% 
gave positive reactions in 352 (7.7%), irritant reactions in 178 (3.9%), and doubtful reactions 
in 132 (2.9%). 119 patients with crescendo reactions to 0.3% limonene would have been 
missed if only tested with 0.1%. 131 patients with crescendo reactions to 1.0% linalool 
would have been missed if only tested with 0.25%. In almost two-thirds of patients with 
positive patch tests to limonene and linalool the reaction was clinically relevant. The 
majority of patients did not react to any fragrance marker in the baseline series.  
Conclusions: 
We recommend that limonene hydroperoxides be tested at 0.3% and linalool 
hydroperoxides at 1.0% in the British baseline patch test series. 
 
Background  
Limonene and linalool are terpene fragrances of natural origin present in the majority of 
detergents and cosmetics purchased by the UK consumer.1 While uncommon fragrance 
allergens in their natural state, they become potent allergens following air-oxidation.2 The 
newly-formed oxidation products include hydroperoxides, largely responsible for 
sensitisation.  
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Limonene, the main constituent of citrus peel oil, has a fresh lemon aroma and is found in 
half of all household detergents and 98% of women’s fragrances.1,3 Linalool has a flowery 
smell and is present in a variety of essential oils including lavender, jasmine, geranium, 
ylang-ylang, rosewood and sage. Similarly to limonene, it is found in most fine fragrances.4 It 
has been identified as the fragrance terpene to which there is the most frequent 
exposure.3,5 
European legislation stipulates that 26 named fragrances, including limonene and linalool, 
must be indicated in the list of ingredients on cosmetic and detergent products, if their 
concentration exceeds 0.001% (10ppm) in leave-on products (e.g. a moisturiser) and 0.01% 
(100ppm) in rinse-off products (e.g. a shampoo). If they are added as part of an essential oil, 
consumers may not be aware of their presence in certain products.6 Although essential oils 
containing limonene and linalool should have them listed on the label if present at threshold 
levels of 10ppm in the finished product for leave on and 100ppm for rinse off products, 
aromatherapy products are not covered by the Cosmetics Regulations. (Regulation (EC) No. 
1223/2009). A widely-used household cosmetic brand marketed in the UK labelled ‘no 
artificial perfume or colour’, contains unlabelled limonene and linalool, inherent 
constituents of pelargonium graveolens (geranium) oil.  
Commercial patch test preparations of oxidised limonene and linalool have in 2012 become 
available from Chemotechnique Diagnostics (Vellinge, Sweden) (Hydroperoxides of 
limonene 0.3% in petrolatum (pet.) (H-032A) and Hydroperoxides of linalool 1.0% pet (H-
031A)), but are not routinely tested.  
A recent national UK audit, published in 2014, demonstrated a significant rate of allergy to 
limonene hydroperoxides 0.3% and linalool hydroperoxides 1.0%.2 However, in this audit 
the numerous doubtful and irritant reactions had not been grouped separately for purposes 
of analysis, nor had data been gathered on concomitant reactions to other fragrance 
markers and on clinical relevance.  
The ideal concentration for patch testing oxidised terpenes would keep doubtful and irritant 
reactions to an acceptable level whilst optimising the chances of detecting a true contact 
allergy, and minimising the risk of active sensitisation. Hence, a further audit, intended to 
determine the optimal concentration of terpene hydroperoxides for patch testing, was set 
up. The intentions were: 1.To specifically compare 3 concentrations of each terpene 
hydroperoxide; 2.To distinguish irritant from doubtful reactions; 3.To assess concomitant 
reactions to other fragrance markers; and 4.To address the issue of clinical relevance.    
 
Method 
During a twelve month period between October 2013 and October 2014, data were 
collected from 12 UK and Irish dermatology departments (Bath, Birmingham, Cardiff, Cork, 
Dundee, East Kent, Leeds, Leicester, Newport, Oxford, Sheffield and Swansea).  4563 
consecutive patients (including a small number of children and adolescents) were tested to 
an extended British baseline patch test series including hydroperoxides of limonene at 
concentrations of 0.3%, 0.2% and 0.1% pet. (equivalent to oxidised limonene 3.0%, 2.0% 
and 1.0% respectively), and hydroperoxides of linalool 1.0%, 0.5% and 0.25% pet.(equivalent 
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to oxidised linalool 6.0%, 3.0% and 1.5% respectively), plus other series as clinically 
indicated.  All allergens were produced by Chemotechnique Diagnostics, who confirmed the 
content of hydroperoxides. The batch to batch variation was: limonene hydroperoxide 0.3%; 
0.27-0.33%, linalool hydroperoxide 1.0%; 0.95-1.05%, limonene hydroperoxide 0.2%; 0.18-
0.22%, linalool hydroperoxide 0.5%; 0.47-0.53%, limonene hydroperoxide 0.1%; 0.09-0.11%, 
linalool hydroperoxide 0.25%; 0.24-0.26%.    
 
Allergens were stored and dispensed according to manufacturers’ instructions, used within 
the recommended stability periods (8 months for limonene, 12 months for linalool), and 
were laid out immediately prior to application by experienced patch test nurses.  8mm Finn 
Chambers® (Epitest Oy, Tuusula, Finland) on Scanpor® tape (Norgesplaster A/S, Vennsela, 
Norway) were used in 11 centres. One centre (Swansea) used IQ UltimateTM chambers. The 
amount of allergen applied was enough to fill the well of the disk but not extrude when the 
patch was applied to the patient’s back, approximately 20 mg (40 mg/cm2) for Finn 
chambers and 25 mg (36 mg/cm2) for IQ chambers. Patches were applied for 48 hours.  
Readings were carried out on Day 2 (D2) and 4 (D4) (or day 5 (D5) in one centre) by a 
dermatologist experienced in interpreting patch tests.  Allergic patch test reactions were 
scored according to the guidelines of the International Contact Dermatitis Research Group 
criteria (Table 1).7 Irritant (IR) reactions were characterised as well-defined erythema at D2 
limited to the exposure area with a lack of infiltrate and with a decrescendo effect between 
D2 and D4/5, particularly in patients who had irritant reactions to other known irritant 
patch test preparations, or to the Scanpor tape. Sharp-edged margins and a wrinkled test 
area surface were other features indicative of irritant reactions. Doubtful (?+) reactions 
were defined as homogenous macular erythema with minimum to no infiltration, limited to 
the exposure area, without a decrescendo effect, or appearing only at D4.  
Clinical relevance was determined as either relevant or of unknown relevance by the 
clinician doing the final patch test reading. Examples of relevant reactions were those in 
patients with a clear current or previous history of fragrance allergy, or dermatitis from a 
product labeled to contain limonene or linalool, or dermatitis from a botanical oil with 
limonene or linalool as a constituent, or a positive repeated open application test to such a 
product. The frequency of positive reactions to each concentration of limonene and linalool 
hydroperoxide, and the clinical characteristics of patients were recorded. These included 
age, sex, presence of atopic dermatitis and duration of rash. Reactions to the other 
fragrance markers in the baseline series (Fragrance mix (FM)1, FM2, Myroxylon pereirae, 
Hydroxyisohexyl 3-cyclohexene carboxaldehyde and colophonium) were recorded.  
We compared associations between age, gender, duration and history of atopic dermatitis, 
and presence of a positive patch test to either limonene 0.3% or linalool 1.0% on day 4/5. 
We used Chi square test for categorical variables (gender, history of atopy), analysis of 
variance (ANOVA) for continuous (age) and Kruskal-Wallis for continuous non-normal 
variables (duration of dermatitis). Due to the repeated nature of the data collected, we used 
Bhapkar’s test of marginal homogeneity to compare reactions to limonene and linalool at 
each concentration on the same day and between day 2 and day 4. All analyses were 
undertaken using R version 3.3.2.  
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Results 
A total of 4563 patients were patch tested at 12 UK centres (Table 2). 463 (10.1%, 95% CI 
9.3%-11.1%) had positive patch test reactions (1+, 2+, or 3+) to one or both terpene 
hydroperoxides on D4/5: 111 (2.4%, 95% CI 2.0%-2.9%) were positive to limonene 
hydroperoxide 0.3% alone and 222 (4.9%, 95% CI 4.3%-5.5%) to linalool hydroperoxide 1.0% 
alone (Figure 1).  130 of the 463 (2.8%, 95% CI 2.4%-3.4% of the 4563 tested) had a positive 
reaction (1+, 2+ or 3+) to both limonene and linalool. Hence the total number positive to 
limonene 0.3% was 241 (5.3%, 95% CI 4.7%-6.0%) and the total positive to linalool 1.0% was 
352 (7.7%, 95% CI 7.0%-8.5%). 93 (2.0%, 95% CI 1.7%-2.5%) irritant reactions to limonene 
hydroperoxide 0.3% were recorded and 178 (3.9%, 95% CI 3.4%-4.5%) to linalool 
hydroperoxide 1.0% (Table 2).  110 (2.4%, 95% CI 2.0%-2.9%) had doubtful reactions to 
limonene hydroperoxide 0.3% and 132 (2.9%, 95% CI 2.4%-3.4%) had doubtful reactions to 
linalool hydroperoxide 1.0%.  
The results from the 5 largest centres testing more than 500 patients per year, all of whom 
used 8mm Finn chambers and a standardised dose, are almost identical to our overall 
results; 163/3091 (5.3%) of patients were positive to limonene hydroperoxides 0.3% and 
245/3091 (7.9%) to linalool hydroperoxides 1.0%.  
The mean (+ SD) age of the 241 patients with 1+ to 3+ positive reactions to limonene 
hydroperoxide 0.3% was 41.3 years (SD 18.1).  There were 166 females (81.0%).  The 
median duration of dermatitis was 24 months (IQR 12-60). 81 (33.6%) were atopic.  The 
mean (+SD) age of the 352 patients with 1-3+ positive reactions to linalool hydroperoxide 
1.0% was 45.0 years (SD 19.2).  There were 226 females (77.4%).  The median duration of 
dermatitis was 33 months (IQR 12-60). 113 (32.1%) were atopic (Table 3).    
Table 4 shows the effect of increasing concentration on the number of negative, positive, 
doubtful and irritant reactions at D2 and D4/5 for limonene and linalool. At D4/5, 0.1% 
limonene had the lowest rate of positive reactions (1.3%), and 1.0% linalool the highest rate 
(7.7%). As the concentration of limonene and linalool increased, the rate of both positive 
and irritant reactions increased (all p-values < 0.001). 
Looking for a crescendo effect, indicative of true allergic positive reactions,8 we compared 
patch test reactions on day 2 versus day 4 at the different concentrations of limonene and 
linalool. When testing with limonene 0.3% (Tables 5a-5c; Figure 2), 161 patients had 
negative patch tests on D2 which became positive on D4, compared with 100 at 0.2%, and 
42 at 0.1%.  When testing with linalool 1.0% (Tables 5d-5f; Figure 3), 194 patients had 
negative patch tests on D2 which became positive on D4, compared with 128 at 0.5%, and 
63 at 0.25%. We found more positive reactions on day 4 versus day 2 for both limonene and 
linalool at all concentrations (all P-values < 0.001).  
Clinical relevance was recorded in 1017 of the 1047 patients who had IR, ?+, or 1+ to 3+ 
positive reactions to limonene or linalool. In almost two-thirds of patients with positive 
patch tests to limonene and linalool the reaction was deemed clinically relevant. Increasing 
the concentration of limonene and linalool had no effect on clinical relevance (Table 6).  
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Concomitant reactions were recorded in 824 of the 1047 patients who had an irritant, ?+, or 
1+ to 3+ positive reaction to limonene or linalool hydroperoxide.  There was no correlation 
between the concentrations of limonene and linalool and the percentage of patients with 
concomitant positive reactions to other fragrance markers. In patients with 2+ and 3+ 
reactions, reactions to other baseline series fragrance markers appeared more frequent 
than in those with 1+, irritant, doubtful or negative reactions, however the numbers of 
patients were small in the 2+/3+ group (statistical analysis was not performed). (Tables 7 
and 8; Figures 4 and 5). Only 229 of the 824 patients (27.8%) reacted to any other fragrance 
marker in the baseline series. 
 
Discussion 
This large multicentre UK audit confirms the high rate of allergy to 0.3% limonene 
hydroperoxides (5.3%) and 1% linalool hydroperoxides (7.7%) in consecutively patch tested 
patients, which we previously reported.2 A very similar rate of contact sensitization to 0.3% 
limonene hydroperoxides of 5.1% has recently been reported in Spain.9 Our results, 
however, show higher rates of positive patch tests than two recent international 
multicentre studies of consecutive dermatitis patients from 6-9 test centres, which showed 
positive reactions to R-limonene hydroperoxides 0.3% in 2.3% of 2411 patients and oxidised 
linalool 1.0% in 5.3% of 2900 patients respectively.10,11  
We found a broadly similar rate of questionable (doubtful and irritant) reactions as we had 
previously. Limonene 0.3% had a rate of irritant reactions of 2.0% and doubtful reactions of 
2.4% and linalool 1.0% had a rate of irritant reactions of 3.9% and doubtful reactions of 
2.9%. This gives a combined rate of doubtful and irritant reactions to limonene of 4.4% and 
to linalool of 6.8%, very similar to the overall rate of 7.3% in our previous paper, where 
irritant and doubtful reactions to limonene and linalool were grouped together.2 In a recent 
international multicentre study the combined rate of irritant and doubtful reactions to 0.3% 
limonene hydroperoxides was 7.9% (irritant 0.9% and doubtful 7.0%).11 In another study, 
using 1% linalool hydroperoxides, the combined rate of irritant and doubtful reactions was 
6.7%, irritant 0.14-0.3% and doubtful 6.4%).12   
Differences in rates of irritant and doubtful reactions between studies illustrate the great 
difficulty in interpretation of patch test results to these chemicals. These differences are 
also seen within studies, for example Table 2 illustrates the variation between centres in our 
audit in rates of irritant reactions: from 0-6.8% for limonene and 0-17% for linalool. Similarly, 
doubtful reactions ranged from 0-17.3% for limonene 0.3% and 0.3-19.2% for linalool 1%. 
Interpretation of positive patch test reactions requires experienced clinical judgement and is 
a particular challenge with oxidized terpenes. It should be acknowledged that in this audit 
patch tests were read on differing days in different centres, with some centres having a D5 
reading, which could influence the rate of irritant reactions. 
A Repeated Open Application Test (ROAT), is recommended in The European Society of 
Contact Dermatitis guidelines to be carried out in cases of doubtful reactions.13 An 
alternative or additional method is to test serial dilutions of the allergen,13 as irritant 
reactions may abruptly disappear at lower concentrations whereas allergic reactions may 
show a gradually reducing strength of response with reducing concentration. Dilutions of 
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hydroperoxides of limonene and linalool are now commercially available from 
Chemotechnique (0.2% hydroperoxides of limonene (H-032B) and 0.5% hydroperoxides of 
linalool (H-031B). 
Brasch et al. showed that crescendo or plateau reaction patterns at Days 1 to 3 were 
significantly more often observed in relevant allergic reactions.8 We used a crescendo or 
plateau pattern to assist in distinguishing positive from doubtful and irritant reactions. As 
the concentration of limonene increased, the greatest difference in detection rates of 
patients with negative patch tests at D2 becoming positive at D4/5 (crescendo reactions) 
was when the concentration of limonene was increased from the lowest concentration, 
0.1%, to the highest, 0.3%, resulting in an extra 119 patients with allergy to limonene being 
detected who would otherwise have been missed. The same was found for the increase in 
concentration of linalool from 0.25% to 1.0%, when 131 extra patients with linalool allergy 
were detected. The highest concentrations, 0.3% limonene and 1.0% linalool hydroperoxide 
respectively, also demonstrated the largest number of cases where a questionable reaction 
at D2 became a definite positive reaction at D4. This supports the need to test the highest 
concentrations for both limonene and linalool, as testing at 0.1% or 0.2% limonene and 
0.25% or 0.5% linalool only would miss these cases.  
The rate of irritant reactions also increased with increasing concentrations.  For limonene, 
the rate of irritant reactions increased from 0.6-2.0% as the concentration increased from 
0.1-0.3%. For linalool the rate of irritant reactions increased from 1.1-3.9% as the 
concentration increased from 0.25-1.0%. It is our opinion that this increase in rate of irritant 
reactions, while undesirable, is counterbalanced by the increase in detection of sensitisation 
cases at higher concentrations.  
Clinical relevance in patients with positive reactions was present in almost two-thirds of our 
patients, but there was no correlation between increasing concentration of limonene and 
linalool hydroperoxide and clinical relevance. A recent international study found that 
exposure to products containing limonene was assessed as being relevant for the patient’s 
dermatitis in only 36% of all patients with a positive patch test to 0.3% limonene 
hydroperoxide. However, in the subgroup of patients attending Barcelona and Copenhagen, 
more than 70% were deemed as relevant, similar to our results.12 
Recent international multicentre studies showed that only approximately 40% of patients 
reacting to oxidized linalool and/or R-limonene had concomitant reactions to other markers 
of fragrance allergy, in keeping with our finding that more than two-thirds of patients 
sensitised to oxidized terpenes do not have this detected by fragrance screening markers in 
the baseline patch test series.10,11 These results are also supported by the finding of Matura 
et al. that only 29-33% of patients with positive patch tests to oxidized R- or S-limonene also 
reacted to other fragrance markers,14 and by other studies.15-17 A recent paper showed 
concomitant reactions to another baseline series fragrance marker to occur in 42.1% of 
patients reacting to 0.3% limonene hydroperoxides18 and 39.5% reacting to 1.0%. linalool 
hydroperoxides, fairly similar to our overall results18.  
In our study, there was no clear relationship between the patch test concentration of 
limonene and linalool and reactions to other fragrance markers. We did, however, find that 
patients with 2+ and 3+ reactions appeared more likely to have reactions to other fragrance 
markers than those with 1+ reactions, although the numbers of patients with 2+/3+ 
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reactions were small.  This is in keeping with Christensson’s finding (testing oxidized linalool 
4.0% - 11% pet.) that the strength of the positive patch test reaction correlated with the 
likelihood of a positive patch test to other fragrance markers, being 28-43% in patients with 
1+ reactions and 75-80% in patients with 2-3+ reactions.19 The same authors have shown 
that cross-reactivity of hydroperoxide haptens only occurs where the haptens have overall 
very similar structures.20 We also found that positivity to other fragrance markers could not 
be used to clearly distinguish allergic from doubtful reactions. Our results clearly illustrate 
that standard screening markers for fragrance allergy in the baseline series (such as FM 1 + 
2) are not adequate to detect allergy to oxidised terpenes. Patients with fragrance allergy 
will be missed unless oxidised limonene and linalool are routinely tested.  
Atopic dermatitis did not appear to be associated with positive (1+ to 3+) versus irritant or 
doubtful reactions to limonene or linalool although one might have expected irritant 
reactions to be more frequent in atopic patients. A previous report found no association 
between atopy and allergy to FM 1.21  
It has been demonstrated, through repeated open application testing, that exposure to low 
concentrations of oxidised linalool causes eczema in allergic patients.22 This is highly 
relevant for many consumers previously sensitised to oxidised linalool since they may be at 
risk of elicitation of dermatitis with the low concentrations present in everyday personal 
hygiene products. The increasing use of ‘natural ingredient based cosmetics’ is a further 
hazard, as these contain essential oils (which may already contain oxidised terpenes when 
received from a producer,18 or can subsequently oxidise during storage23). Pesonen et al. 
reported occupational hand dermatitis due to exposure to cosmetic products scented with 
limonene.24 The range in occupational groups affected by dermatitis to oxidised limonene is 
broad; from laboratory technicians to masseurs.12 
 
Unless oxidised limonene and linalool are used as a screen for fragrance allergy, patients 
with clinically relevant sensitisation will be missed. Therefore, we suggest that the baseline 
British patch test series is extended to include limonene hydroperoxides 0.3% (H-032A) and 
linalool hydroperoxides 1.0% (H-031A). Patients with doubtful reactions should have a ROAT 
with suspected products or have dilutions of the hydroperoxides tested (0.2% 
hydroperoxides of limonene and 0.5% hydroperoxides of linalool). 
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Table 1.  Scoring of patch tests according to the International Contact Dermatitis Research 
Group.7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Score Reaction 
0 Negative 
?+ Doubtful: erythema only 
1+ Weak (non-vesicular) positive allergic reaction; erythema, infiltration 
and possibly papules 
2+ Strong (vesicular) positive allergic reaction; erythema, infiltration, 
papules and vesicles 
3+ Extreme positive allergic reaction; bullous reaction 
IR Irritant reaction 
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  Limonene 0.3% day 4/5 Linalool 1.0% day 4/5 
Site Total tested Irritant ?+ 1+/2+/3+ Irritant ?+ 1+/2+/3+ 
  N % N % N % N % N % N % 
Centres seeing 
500 + 
patients/year 
  
Leeds 758 0 0.0 5 0.7 26 3.4 0 0.0 5 0.7 34 4.5 
Oxford 695 13 1.9 0 0.0 46 7.0 13 1.9 5 0.7 43 6.1 
Dundee 557 24 4.3 8 1.4 50 9.4 61 11.0 14 2.5 78 14.3 
Newport 550 4 0.7 1 0.2 18 3.0 4 0.7 4 0.7 37 7.0 
Sheffield 531 36 6.8 33 6.2 23 4.6 64 12.1 43 8.1 53 10.1 
Subtotal 3091 77 2.5 47 1.5 163 5.3 142 4.6 71 2.3 245 7.9 
Centres seeing 
<500 
patients/year 
  
Leicester 341 6 1.8 2 0.6 9 2.3 8 2.3 1 0.3 12 3.3 
Cardiff 281 0 0.0 1 0.4 14 5.0 0 0.0 1 0.4 21 7.0 
Birmingham 250 0 0.0 23 9.2 0 0.0 0 0.0 24 9.6 0 0.0 
Swansea 191 0 0.0 11 5.8 32 17 0 0.0 8 4.2 32 17 
Bath 165 10 6.1 3 1.8 4 2.2 28 17.0 1 0.6 10 6.0 
East Kent 140 0 0.0 5 3.6 11 7.9 0 0.0 6 4.3 26 18.6 
Cork 104 0 0.0 18 17.3 8 8.0 0 0.0 20 19.2 6 6.0 
Subtotal 1472 16 1.1 63 4.3 78 5.3 36 2.4 61 4.1 107 7.3 
All 4563 93 2.0 110 2.4 241 5.3 178 3.9 132 2.9 352 7.8 
Table 2.  Total number of patients patch tested at each centre and the number and 
percentage of irritant, doubtful and positive reactions to hydroperoxides of (a) limonene 
0.3% and (b) linalool 1.0% at day 4/5. There are subtotals for the five centres patch testing 
larger numbers of patients (500+ per year) as well as a subtotal for the remaining seven 
centres patch testing less than 500 patients per year. 
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 Irritant ?+ 1/2/3+ p value 
Limonene 0.3% D4/5     
N 93 110 241  
Mean age (SD)1 52.3 (18.6) 43.3 (18.9) 41.3 (18.1) <0.001 
Female gender        
N (%)2 
48 (67.6%) 83 (79.8%) 166 (81.0%) 0.06 
Median duration, 
months (IQR)3 
36 (12-90) 24 (12-84) 24 (12-60) 0.45 
Atopic N (%)2 33 (35.9%) 29 (33.7%) 81 (33.6%) 0.95 
Linalool 1.0% D4/5     
N 178 132 352  
Mean age (SD) 1 50.6 (17.8) 45.5 (19.6) 45.0 (19.2) 0.03 
Female gender        
N (%)2 
87 (69.6%) 92 (76.7%) 226 (77.4%) 0.22 
Median duration, 
months (IQR)3 
24 (12-60) 24 (12-84) 33 (12-60) 0.55 
Atopic N (%)2 62 (35.6%) 36 (34.3%) 113 (32.1%) 0.83 
Table 3. Demographics of 1047 patients with irritant (IR), doubtful (?+) or positive patch test 
(1 to 3+) reactions to limonene 0.3% and linalool 1.0% on Day 4/5. Patients with irritant 
reactions were significantly older than those with 1+ or 2+/3+ reactions, for both limonene 
and linalool.1p values from ANOVA, 2p values from Chi square test, 3p values from Kruskal-
Wallis test. 
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(a) 
 0.1% Limonene 0.2% Limonene 0.3% Limonene 
  Day 2 Day 4/5 Day 2 Day 4/5 Day 2 Day 4/5 
 N % N % N % N % N % N % 
Negative 4517 99.0 4424 97.0 4449 97.5 4278 93.8 4364 95.6 4119 90.3 
Irritant 8 0.2 28 0.6 31 0.7 40 0.9 66 1.4 93 2.0 
?+ 27 0.6 53 1.2 50 1.1 98 2.1 84 1.8 110 2.4 
1+/2+/3+ 11 0.2 58 1.3 33 0.7 147 3.2 49 1.1 241 5.3 
 
(b) 
 0.25% Linalool 0.5% Linalool 1.0% Linalool 
  Day 2 Day 4/5 Day 2 Day 4/5 Day 2 Day 4/5 
 N % N % N % N % N % N % 
Negative 4419 96.8 4264 93.4 4290 94.0 4086 89.5 4123 90.4 3901 85.5 
Irritant 36 0.8 51 1.1 80 1.8 89 2.0 184 4.0 178 3.9 
?+ 72 1.6 133 2.9 121 2.7 157 3.4 173 3.8 132 2.9 
1+/2+/3+ 36 0.8 115 2.5 72 1.6 231 5.1 83 1.8 352 7.7 
Table 4. Effect of increasing concentration on the number of negative, irritant, doubtful and 
positive reactions on day 2 and day 4/5 for (a) limonene and (b) linalool. 
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 0.1% Limonene, Day 4  
  
0.1% Limonene, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4411 
97.7% 
  
25 
0.6% 
  
39 
0.9% 
  
37 
0.8% 
  
5 
0.1% 
  
4517 
 
Irritant 
N 
Row(%) 
  
0 
0.0% 
  
3 
37.5% 
  
2 
25.0% 
  
3 
37.5% 
  
0 
0.0% 
  
8 
 
?+ 
N 
Row(%) 
  
9 
33.3% 
  
0 
0.0% 
  
11 
40.7% 
  
6 
22.2% 
  
1 
3.7% 
  
27 
 
1+ 
N 
Row(%) 
  
4 
36.4% 
  
0 
0.0% 
  
1 
9.1% 
  
5 
45.5% 
  
1 
9.1% 
  
11 
 
2+/3+ 
N 
Row(%) 
  
0 
0% 
  
0 
0% 
  
0 
0% 
  
0 
0% 
  
0 
0% 
  
0 
 
Total 4424 28 53 51 7 4563 
Table 5a. 0.1% limonene: Day 2 versus Day 4. 
 
 
 0.2% Limonene, Day 4  
  
0.2% Limonene, Day 2 Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4239 
95.3% 
  
28 
0.6% 
  
82 
1.8% 
  
97 
2.2% 
  
3 
0.0% 
  
4449 
 
Irritant 
N 
Row(%) 
  
14 
45.2% 
  
11 
35.5% 
  
2 
6.5% 
  
4 
12.9% 
  
0 
0.0% 
  
31 
 
?+ 
N 
Row(%) 
  
20 
40.0% 
  
1 
2.0% 
  
12 
24.0% 
  
16 
32.0% 
  
1 
2.0% 
  
50 
 
1+ 
N 
Row(%) 
  
5 
15.6% 
  
0 
0.0% 
  
2 
6.2% 
  
21 
65.6% 
  
4 
12.5% 
  
32 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
1 
100.0% 
  
1 
 
Total 4278 40 98 138 9 4563 
Table 5b. 0.2% limonene: Day 2 versus Day 4. 
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 0.3% Limonene, Day 4  
  
0.3% Limonene, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4062 
93.1% 
  
66 
1.5% 
  
75 
5.5% 
  
157 
3.6% 
  
4 
0.1% 
  
4364 
 
Irritant 
N 
Row(%) 
  
31 
47.0% 
  
24 
36.4% 
  
3 
4.5% 
  
8 
12.1% 
  
0 
0.0% 
  
66 
 
?+ 
N 
Row(%) 
  
21 
25.0% 
  
2 
2.4% 
  
27 
32.1% 
  
32 
38.1% 
  
2 
2.4% 
  
84 
 
1+ 
N 
Row(%) 
  
5 
11.4% 
  
1 
2.3% 
  
5 
11.4% 
  
29 
65.9% 
  
4 
9.1% 
  
44 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
5 
100.0% 
  
5 
 
Total 4119 93 110 226 15 4563 
Table 5c. 0.3% limonene: Day 2 versus Day 4. 
 
 
 0.25% Linalool, Day 4  
  
0.25% Linalool, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4228 
95.7% 
  
33 
0.7% 
  
95 
2.1% 
  
61 
1.4% 
  
2 
0.0% 
  
4419 
 
Irritant 
N 
Row(%) 
  
11 
30.6% 
  
15 
41.7% 
  
4 
11.1% 
  
6 
16.7% 
  
0 
0.0% 
  
36 
 
?+ 
N 
Row(%) 
  
21 
29.2% 
  
2 
2.8% 
  
32 
44.4% 
  
16 
22.2% 
  
1 
1.4% 
  
72 
 
1+ 
N 
Row(%) 
  
4 
11.8% 
  
1 
2.9% 
  
2 
5.9% 
  
26 
76.5% 
  
1 
2.9% 
  
34 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
0 
0.0% 
  
1 
50.0% 
  
1 
50.0% 
  
2 
 
Total 4264 51 133 110 5 4563 
Table 5d. 0.25% linalool: Day 2 versus Day 4. 
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 0.5% Linalool, Day 4  
  
0.5% Linalool, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
4007 
93.4% 
  
55 
0.3% 
  
100 
2.3% 
  
121 
2.8% 
  
7 
0.2% 
  
4290 
 
Irritant 
N 
Row(%) 
  
40 
50.0% 
  
25 
31.2% 
  
8 
10.0% 
  
7 
8.8% 
  
0 
0.0% 
  
80 
 
?+ 
N 
Row(%) 
  
33 
27.3% 
  
6 
5.0% 
  
40 
33.1% 
  
41 
33.9% 
  
1 
0.8% 
  
121 
 
1+ 
N 
Row(%) 
  
6 
9.4% 
  
3 
4.7% 
  
8 
12.5% 
  
45 
70.3% 
  
2 
3.1% 
  
64 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
0 
0.0% 
  
1 
12.5% 
  
4 
50.0% 
  
3 
37.5% 
  
8 
 
Total 4086 89 157 218 13 4563 
Table 5e. 0.5% linalool: Day 2 versus Day 4. 
 
 
 
 1.0% Linalool, Day 4  
  
1.0% Linalool, Day 2 
 
Negative 
  
Irritant 
  
?+ 
  
1+ 
  
2+/3+ 
  
Total 
Negative 
N 
Row(%) 
  
3761 
91.2% 
  
97 
2.4% 
  
71 
1.7% 
  
177 
4.3% 
  
17 
0.4% 
  
4123 
 
Irritant 
N 
Row(%) 
  
96 
52.2% 
  
63 
34.2% 
  
10 
5.4% 
  
15 
8.2% 
  
0 
0.0% 
  
184 
 
?+ 
N 
Row(%) 
  
41 
23.7% 
  
14 
8.1% 
  
48 
27.7% 
  
65 
37.6% 
  
5 
2.9% 
  
173 
 
1+ 
N 
Row(%) 
  
3 
4.0% 
  
3 
4.0% 
  
3 
4.0% 
  
56 
74.7% 
  
10 
13.3% 
  
75 
 
2+/3+ 
N 
Row(%) 
  
0 
0.0% 
  
1 
12.5% 
  
0 
0.0% 
  
3 
37.5% 
  
4 
50.0% 
  
8 
 
Total 3901 178 132 316 36 4563 
Table 5f. 1.0% linalool: Day 2 versus Day 4. 
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 Unknown 
relevance 
Clinically 
relevant 
Total positive           
(1+, 2+, 3+) 
0.1% limonene 19 (33.3%) 38 (66.7%) 57 
0.2% limonene 51 (35.4%) 93 (64.6%) 144 
0.3% limonene 78 (33.5%) 155 (66.5%) 233 
0.25% linalool 47 (41.2%) 67 (58.8%) 114 
0.5% linalool 76 (33.2%) 153 (66.8%) 229 
1.0 % linalool  124 (36.4%) 217 (63.6%) 341 
Table 6. Effect of increasing concentration on clinical relevance for limonene and linalool. 
Relevance data were recorded in 1017 of the 1047 patients who had irritant, ?+, 1+, or 
2+/3+ reactions to hydroperoxides of limonene or linalool. 
 
 Positivity to other fragrance markers 
Limonene, Day 4 0.1% 0.2% 0.3% 
Negative 
N 
Row(%) 
  
191 
26.9% 
  
156 
26.9% 
  
102 
22.3% 
Irritant 
N 
Row(%) 
  
4 
20.0% 
  
6 
16.2% 
  
18 
29.0% 
?+ 
N 
Row(%) 
  
15 
31.9% 
  
20 
25.6% 
  
34 
38.2% 
1+ 
N 
Row(%) 
  
16 
37.2% 
  
43 
35.0% 
  
67 
32.7% 
2+/3+ 
N 
Row(%) 
  
3 
75.0% 
  
4 
66.7% 
  
8 
80.0% 
Table 7. Day 4 Limonene 0.1%, 0.2%, 0.3%: Proportion of people with positivity to other fragrance 
markers (recorded in 824 of the 1047 patients; 229 (27.8%) of these had a positive reaction to 
another fragrance marker). 
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 Positivity to other fragrance markers 
 Linalool, Day 4 0.25% 0.5% 1.0% 
Negative 
N 
Row(%) 
  
132 
23.0% 
  
96 
22.5% 
  
60 
19.9% 
Irritant 
N 
Row(%) 
  
8 
18.6% 
  
10 
13.5% 
  
21 
17.4% 
?+ 
N 
Row(%) 
  
42 
38.2% 
  
39 
29.5% 
  
35 
32.1% 
1+ 
N 
Row(%) 
  
45 
47.9% 
  
80 
43.2% 
  
100 
36.6% 
2+/3+ 
N 
Row(%) 
  
2 
66.7% 
  
4 
66.7% 
  
13 
65.0% 
Table 8. Day 4 linalool 0.25%, 0.5%, 1.0%: proportion of people with positivity to other fragrance 
markers (recorded in 824 of the 1047 patients; 229 (27.8%) of these had a positive reaction to 
another fragrance marker). 
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Figure 1. Concomitant  positive patch test reactions between oxidised limonene 0.3% and 
oxidised linalool 1.0%. A total of 463 (10.1%) had positive patch test reactions (1+, 2+, or 3+) 
to one or both terpene hydroperoxides on D4/5: 111 (2.4%) were positive to limonene 
hydroperoxide 0.3% alone and 222 (4.9%) to linalool hydroperoxide 1.0% alone.  130 of the 
463 had a positive reaction (1+, 2+ or 3+) to both limonene and linalool.   
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Figure 2. Change in patch test results from negative to positive between Day 2 and Day 4/5 
at different concentrations of limonene. 
 
 
Figure 3. Change in patch test results from negative to positive between Day 2 and Day 4/5 
at different concentrations of linalool. 
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Figure 4. Patch test concentration of limonene and concomitant reactions to other 
fragrance markers (n=824). 
 
 
Figure 5. Patch test concentration of linalool and concomitant reactions to other fragrance 
markers (n=824).  
